Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Vehicle Recompete: Idc 75N91022D00010

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract 75N91022D00010 is an indefinite delivery contract vehicle for scientific and technical support services related to tobacco control research, managed by the National Cancer Institute (NCI) under the Department of Health and Human Services. It is a full recompete contracting vehicle with a total ceiling value of $15 million and an ordering period running until July 31, 2027. The contract is set aside specifically for 8(a) small businesses and originates from the solicitation number 75N91021R00028. Currently, no active task orders are valued at zero, but notable previous task orders include significant projects such as the development, production, and dissemination of the NCI Tobacco Control Monograph, valued at over $1.5 million, along with coordination efforts for cancer health equity workshops and patient engagement network logistics. The contract falls under NAICS code 541990, which covers professional scientific and technical services, supporting the NIH's mission to research and control tobacco-related health issues. The largest task awards have been assigned to Strategix Management LLC, which has conducted high-profile tasks related to monograph production, workshop coordination, and network logistics. The vehicle’s recompete phase was posted ahead of time in early 2026 to ensure continuous support, allowing potential bidders to prepare for solicitation. This contract vehicle plays a critical role in facilitating scientific research support tailored for tobacco control efforts under the NIH’s Cancer Institute umbrella.

General Info

Indefinite delivery contract for tobacco control research support, $15M ceiling, set aside 8(a) small businesses.

Agency

Department Of Health And Human Services → NIH NciView Agency

NAICS

541990 - All Other Professional, Scientific, and Technical ServicesView NAICS

Place of Performance

Not specified

Set-Aside

8A

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

pre-forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → NIH Nci
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → NIH Nci
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Idc vehicle 75N91022D00010 ordering period ends 2027-07-31T00:00:00.000Z. 0 active task orders valued at $0.
Tobacco control research scientific and technical services support contract - idiq Original Solicitation: 75N91021R00028 IDV Ceiling: $15,000,000 Set-Aside: 8a competed Contracting Office: NIH Nci Agencies: Department of Health and Human Services Classification: full-recompete (Confidence: high - 85/100)
Top task orders by value: - DEVELOPMENT, PRODUCTION, AND DISSEMINATION OF NCI TOBACCO CONTROL MONOGRAPH ($1,513,810) - STRATEGIX MANAGEMENT LLC - COORDINATION FOR THE CANCER HEALTH EQUITY DESIGN LAB WORKSHOP ($237,254) - STRATEGIX MANAGEMENT LLC - MEETING LOGISTICS AND NETWORK COORDINATION FOR THE PATIENT ENGAGEMENT AND CANCER GENOME SEQUENCING (PE-CGS) NETWORK ($29,037) - STRATEGIX MANAGEMENT LLC

Similar Contracts

Same NAICS industry code

NAICS: 541990
New
Federal
Post-Construction Environmental Compliance Monitoring Services for OR FLAP GRANT 24(2) Granite Hill Road Reconstruction Phase II
Solicitation # 69056726Q000034
Solicitation 69056726Q000034 is a request for quotation issued by the Department of Transportation, Western Federal Lands Division, for post-construction environmental compliance monitoring services supporting the OR FLAP GRANT 24(2) Granite Hill Road Reconstruction Phase II project in Oregon. This acquisition is a total small business set-aside conducted under FAR 12.201-1 simplified procedures. The scope of work requires the contractor to ensure full compliance with the Oregon DEQ NPDES 1200-CA permit, which includes developing and maintaining an Erosion and Sediment Control Plan (ESCP) across four construction phases: demolition and land development, street and utilities, vertical construction, and final landscaping and site stabilization. The contract involves maintaining detailed inspection logs, performing visual monitoring, and providing a Hazardous Spill Plan. The period of performance extends from the date of award through September 30, 2027, with services delivered as firm-fixed price tasks. Technical requirements mandate that the ESCP and engineered facilities be stamped by qualified professionals, such as Oregon Registered Professional Engineers or Landscape Architects, depending on the acreage disturbed. Offerors must submit a price schedule and a past experience submission form, limited to five pages per relevant contract, to be evaluated against specific performance factors. The response deadline was extended via Amendment 0001 to September 10, 2026.
690567 Western Federal Lands Division

POSTED

1 day ago

DEADLINE

in 9 days
View Details

More opportunities from Department Of Health And Human Services → NIH Nci

Same awarding agency

NAICS: 54171
Federal
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
Solicitation # 75N98026R00109
The National Cancer Institute (NCI) is soliciting research proposals from small business concerns for the Small Business Innovation Research (SBIR) Innovative Concept Phase I Award Program under solicitation 75N98026R00109. This high-risk, high-reward program focuses on the development of therapeutic, preventative technologies, devices, diagnostic tools, or digital health tools specifically for pediatric and rare cancers, with a preference for rare cancers having a five-year survival rate of less than 50 percent. The goal is to demonstrate proof-of-concept and feasibility for transformative technologies to derisk them for future Phase I or Phase II awards. While preliminary data is not required, proposals must be based on a sound scientific premise and clearly identify the clinical problem and the anticipated development path. Non-exempt human subjects research is not supported. The program provides a base R&D budget of up to 300,000 dollars for up to 12 months, with an additional 6,500 dollars available for Technical and Business Assistance. Proposals are evaluated on a competitive basis using a triage process and weighted factors, including potential for innovation and impact (50 percent), scientific rationale and approach (20 percent), commercialization potential (20 percent), and personnel and resources (10 percent). Applicants must be registered in the System for Award Management and the SBA Company Registry. Proposals must be submitted via the electronic Contract Proposal Submission portal by 5:00pm on September 21, 2026. Recent amendments have provided a technical proposal form, removed the Data Management Sharing Plan requirement, and provided clarified questions and answers. Offerors are required to submit a signed copy of Amendment 3 with their business proposal.

POSTED

23 days ago

DEADLINE

in 20 days
View Details